Global Fusion Transcript Assays Market was valued at USD 0.3 Billion in 2022 and is projected to reach USD 0.7 Billion by 2030, growing at a CAGR of 11.0% from 2024 to 2030.
The Fusion Transcript Assays Market is experiencing rapid growth due to increasing demand for accurate and efficient gene expression analysis. This market, driven by advancements in genomic technologies, offers valuable insights into genetic variations, making it crucial in fields like diagnostics, personalized medicine, and drug discovery. With the rise of next-generation sequencing (NGS) and advancements in bioinformatics, researchers can now identify fusion genes and their roles in diseases with higher precision and at lower costs. The adoption of fusion transcript assays is revolutionizing molecular oncology, where understanding gene fusions is key to the development of targeted therapies.
Market dynamics show that demand for fusion transcript assays has been expanding as pharmaceutical companies and healthcare providers strive for faster, more reliable diagnostic tools. In 2025, the market is expected to grow at a significant rate due to increasing investments in precision medicine, personalized cancer therapies, and the integration of these assays into clinical settings. The demand for better oncology treatments has propelled the development of fusion transcript assays, particularly for cancers associated with gene rearrangements, such as lung, breast, and colorectal cancers.
Geographically, North America leads the Fusion Transcript Assays Market, owing to advanced healthcare infrastructure and strong research initiatives in genomics. However, Asia-Pacific is expected to witness the fastest growth, driven by rising investments in biotechnology and healthcare in countries like China and India. The increasing availability of affordable sequencing technology and the growing demand for personalized treatments are key factors driving this growth.
Several companies are now focusing on improving the accuracy and speed of fusion transcript assays to meet the increasing demand. Companies are also developing new assays tailored to specific disease types, enhancing their appeal for precision medicine applications. Furthermore, collaborations between academic institutions and private companies are accelerating research and driving innovation in this space, ensuring that the market continues to evolve rapidly.
Get an In-Depth Research Analysis of the Global Fusion Transcript Assays Market Size And Forecast [2025-2032]
Thermo Fisher Scientific
Illumina
Inc.
Merck Millipore
Hologic Inc.
Hologic Inc Bio-Rad Laboratories Inc.
Caris Life Sciences
SeraCare Life Sciences Inc.
QIAGEN
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global Fusion Transcript Assays Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Global Fusion Transcript Assays Market
Hospital
Cancer Research Center
Diagnostic Laboratory
Others
Based on Types the Market is categorized into Below types that held the largest Fusion Transcript Assays market share In 2023.
Fusion Transcript Kits
PCR Devices
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Global, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Fusion Transcript Assays Market Research Analysis
1. Introduction of the Global Fusion Transcript Assays Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Fusion Transcript Assays Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Fusion Transcript Assays Market, By Type
6. Global Fusion Transcript Assays Market, By Application
7. Global Fusion Transcript Assays Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global Fusion Transcript Assays Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/